FDA Clears Takeda’s Orzeyful as Novel Narcolepsy Type 1 Treatment

By Elaine Chen · STAT News · 2026-08-05

According to reporting from STAT News, federal regulators have approved a twice-daily pill from Takeda that targets the underlying orexin deficiency in narcolepsy type 1. This new medication, marketed as Orzeyful, demonstrated significant improvements in daytime alertness and mus

According to reporting from STAT News, federal regulators have approved a twice-daily pill from Takeda that targets the underlying orexin deficiency in narcolepsy type 1. This new medication, marketed as Orzeyful, demonstrated significant improvements in daytime alertness and mus